Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development (includes related party amounts of $8 and $15, respectively)	$ 7,255	$ 2,196
General and administrative (includes related party amounts of $0 and $5, respectively)	3,764	584
Total operating expenses	11,019	2,780
Loss from operations	(11,019)	(2,780)
Other income (expense):
Interest income	109
Other expense		(1)
Total other income (expense)	109	(1)
Net loss before income taxes	(10,910)	(2,781)
Net loss	(10,910)	(2,781)
Comprehensive loss:
Net loss	(10,910)	(2,781)
Other comprehensive loss:
Unrealized loss on available-for-sale investments	(585)
Comprehensive loss	$ (11,495)	$ (2,781)
Net loss per share, basic and diluted	$ (0.45)	$ (11.49)
Weighted-average shares of common stock outstanding, basic and diluted	24,410,393	243,076